AAAAAA

   
Results: 1-9 |
Results: 9
Elevation of serum pro-gastrin-releasing peptide in patients with medullary thyroid carcinoma and small cell lung carcinoma
Authors: Ide, A Ashizawa, K Ishikawa, N Ishii, R Ando, T Abe, Y Sera, N Usa, T Tominaga, T Ejima, E Nakashima, M Ito, K Ito, K Eguchi, K
Citation: A. Ide et al., Elevation of serum pro-gastrin-releasing peptide in patients with medullary thyroid carcinoma and small cell lung carcinoma, THYROID, 11(11), 2001, pp. 1055-1061
Pulmonary nocardiosis associated with idiopathic thrombocytopenic purpura
Authors: Ando, T Usa, T Ide, A Abe, Y Sera, N Tominaga, T Ejima, E Ashizawa, K Nakata, K Eguchi, K
Citation: T. Ando et al., Pulmonary nocardiosis associated with idiopathic thrombocytopenic purpura, INTERN MED, 40(3), 2001, pp. 246-249
Etidronate inhibits human osteoblast apoptosis by inhibition of pro-apoptotic factor(s) produced by activated T cells (vol 136, pg 344, 2000)
Authors: Abe, Y Kawakami, A Nakashima, T Ejima, E Fujiyama, K Kiriyama, T Ide, A Sera, N Usa, T Tominaga, T Ashizawa, K Yokoyama, N Eguchi, K
Citation: Y. Abe et al., Etidronate inhibits human osteoblast apoptosis by inhibition of pro-apoptotic factor(s) produced by activated T cells (vol 136, pg 344, 2000), J LA CL MED, 137(2), 2001, pp. 141-141
Fas/FasL mediated apoptosis of thyrocytes in Graves' disease
Authors: Sera, N Kawakami, A Nakashima, T Nakamura, H Imaizumi, M Koji, T Abe, Y Usa, T Tominaga, T Ejima, E Ashizawa, K Yokoyama, N Ishikawa, N Ito, K Eguchi, K
Citation: N. Sera et al., Fas/FasL mediated apoptosis of thyrocytes in Graves' disease, CLIN EXP IM, 124(2), 2001, pp. 197-207
Thyroid hormones influence serum leptin levels in patients with Graves' disease during suppression of beta-adrenergic receptors
Authors: Sera, N Yokoyama, N Abe, Y Ide, A Imaizumi, M Usa, T Tominaga, T Ejima, E Ashizawa, K Ohmoto, Y Eguchi, K
Citation: N. Sera et al., Thyroid hormones influence serum leptin levels in patients with Graves' disease during suppression of beta-adrenergic receptors, THYROID, 10(8), 2000, pp. 641-646
Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease
Authors: Sera, N Ashizawa, K Ando, T Abe, Y Ide, A Usa, T Tominaga, T Ejima, E Yokoyama, N Eguchi, K
Citation: N. Sera et al., Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease, THYROID, 10(7), 2000, pp. 595-599
Anaplastic changes associated with p53 gene mutation in differentiated thyroid carcinoma after insufficient radioactive iodine (I-131) therapy
Authors: Sera, N Ashizawa, K Ando, T Ide, A Abe, Y Usa, T Tominaga, T Ejima, E Hayashi, T Shimokawa, I Eguchi, K
Citation: N. Sera et al., Anaplastic changes associated with p53 gene mutation in differentiated thyroid carcinoma after insufficient radioactive iodine (I-131) therapy, THYROID, 10(11), 2000, pp. 975-979
CD4(+) T cell-mediated cytotoxicity toward thyrocytes: The importance of Fas/Fas ligand interaction inducing apoptosis of thyrocytes and the inhibitory effect of thyroid-stimulating hormone
Authors: Kawakami, A Matsuoka, N Tsuboi, M Koji, T Urayama, S Sera, N Hida, A Usa, T Kimura, H Yokoyama, N Nakashima, T Ishikawa, N Ito, K Kawabe, Y Eguchi, K
Citation: A. Kawakami et al., CD4(+) T cell-mediated cytotoxicity toward thyrocytes: The importance of Fas/Fas ligand interaction inducing apoptosis of thyrocytes and the inhibitory effect of thyroid-stimulating hormone, LAB INV, 80(4), 2000, pp. 471-484
Etidronate inhibits human osteoblast apoptosis by inhibition of pro-apoptotic factor(s) produced by activated T cells
Authors: Abe, Y Kawakami, A Nakashima, T Ejima, E Fujiyama, K Kiriyama, T Ide, A Sera, N Usa, T Tominaga, T Ashizawa, K Yokoyama, N Eguchi, K
Citation: Y. Abe et al., Etidronate inhibits human osteoblast apoptosis by inhibition of pro-apoptotic factor(s) produced by activated T cells, J LA CL MED, 136(5), 2000, pp. 344-354
Risultati: 1-9 |